share_log

Teva Pharmaceutical Says Trial of Ajovy to Prevent Episodic Migraine in Children Reaches Primary Endpoint

Teva Pharmaceutical Says Trial of Ajovy to Prevent Episodic Migraine in Children Reaches Primary Endpoint

Teva藥品表示,阿喬維預防兒童偶發性偏頭痛試驗已達到主要終點
MT Newswires ·  07/18 09:30

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論